Showing results (171-180 of 384) with videos related to

Sort By:
Pageof 39
Oncotarget|March 5, 2016
Accelerated geroncogenesis in hereditary breast-ovarian cancer syndromeJavier A Menendez, Núria Folguera-Blasco, Elisabet Cuyàs, et al.
The Journal of Endocrinology|October 1, 1990
N-acetyltransferase activity in the Harderian glands of the Syrian hamster, Mesocricetus auratus, is regulated by androgens and by hormones of the pituitary-thyroid axisG R Buzzell, A Menendez-Pelaez, R A Hoffman, et al.
Expert Opinion on Therapeutic Targets|July 11, 2025
Metabolic hallmarks of trastuzumab resistanceBegoña Martin-Castillo, Sara Verdura, Àngela Llop-Hernández, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|July 3, 2025
Study of the interplay between geometry and chemistry in nanoscale hydrationS R Accordino, C A Menendez, N A Loubet, et al.
Journal of Pineal Research|January 1, 1990
Effects of short-day photoperiods and of N-(2,4-dinitrophenyl)-5-methoxytryptamine, a putative melatonin antagonist, on melatonin synthesis in the Harderian gland of the Syrian hamster, Mesocricetus auratusG R Buzzell, A Menendez-Pelaez, M E Troiani, et al.
Journal of Pineal Research|August 1, 1991
Chronic administration of melatonin induces changes in porphyrins and in the histology of male and female hamster harderian gland: interrelation with the gonadal statusM J Rodriguez-Colunga, C Fernandez, I Antolin, et al.
American Journal of Cancer Research|June 13, 2022
Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signalingLin Yang, Travis Vander Steen, Ingrid Espinoza, et al.
International Journal of Oncology|December 22, 2007
Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of schedulingCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Ramon Colomer, et al.
Oncotarget|September 2, 2015
Heregulin, a new interactor of the telosome/shelterin complex in human telomeresJavier A Menendez, Louisa Benboudjema, Luciano Vellon, et al.
International Journal of Molecular Medicine|June 6, 2007
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review)Laura Ferrer-Soler, Alejandro Vazquez-Martin, Joan Brunet, et al.
Pageof 39